Results 301 to 310 of about 343,340 (395)

Tumor Infiltrating Lymphocyte is Present [PDF]

, 2020
openaire   +1 more source

NIR‐Activatable Domino Cascade Catalysis Nanozyme Reactor for Multi‐Mechanism Synergistic Immunotherapy in Bladder Cancer

Advanced Science, EarlyView.
This study presents an intravesical delivery strategy of ferroptosis‐ and immunity‐inducing nanozyme‐loaded thermoresponsive hydrogels (FMCC@PNH) for enhanced bladder cancer therapy. Abstract Current intravesical therapies for bladder cancer after resection are limited by poor tissue penetration, off‐target effects, and insufficient efficacy.
Yongnan Jiang, Qingling Zhang, Yuhan Zhang, Xinlu Yu, Bo Jia, Yulong Dong, Yalong Wu, Kelong Fan, Xinquan Gu, Lei Ji, Wei Jiang, Bin Liu   +11 more
wiley   +1 more source

Highly efficient gene knockout in tumor-infiltrating lymphocytes by adenine base editing. [PDF]

Mol Ther Oncol
Hafezi M, Genolet R, Hadadi L, Chap BS, Bobisse S, Giordano Attianese GMP, El Jorfi H, Cropp D, Pericou L, Arnaud M, Scholten K, Maurouard T, Laniti DD, Harari A, Gentner B, Irving M, Coukos G.   +16 more
europepmc   +1 more source

Population‐Based Multi‐Omics and Cohort Study Identifying Predictive Biomarkers and Therapeutic Targets for Psoriatic Disease

Advanced Science, EarlyView.
Psoriatic disease (PsD) is a chronic skin disease, with challenges in early risk stratification and drug development. Through gene‐level causal inference framework and expression level validation, combined with longitudinal cohort study, CDSN and PRSS8 have been identified as candidate biomarkers and therapeutic targets for PsD.
Tianxing Wu, Jialiang Luo, Haoyuan Qiu, Weijie Shao, Yueyang Lu, Meixuan Luo, Zhaofeng Lin, Yan Zhang, Libo Zhang, Hong Wang, Jia Zhou, Guangfeng Ruan, Peihua Cao, Daming Zuo   +13 more
wiley   +1 more source

Prognostic value of tumor-infiltrating lymphocytes, tumor associated neutrophils and metabolic checkpoint molecules on survival of patients with metastatic pancreatic ductal adenocarcinoma. [PDF]

Surg Pract Sci
Zhang T, Miksch RC, Aghamaliyev U, Weniger M, Günther M, Ormanns S, Parsa F, D'Haese JG, Bazhin AV, Ilmer M, Renz BW, Werner J.   +11 more
europepmc   +1 more source

CHARACTERIZATION OF TUMOR INFILTRATING LYMPHOCYTES FROM PATIENTS WITH RENAL CELL CARCINOMA

, 1996
H Yanagiya, Seiji Kudoh, Shin’ya Takahashi, Tadashi Suzuki   +3 more
openalex   +2 more sources

Antiemesis Corticosteroids Potentiate Checkpoint Blockade Efficacy by Normalizing the Immune Microenvironment in Metastatic Murine Breast Cancer

Advanced Science, EarlyView.
Corticosteroids improve the efficacy of immune checkpoint blockade therapy in metastatic murine breast cancer. By normalizing the tumor immune microenvironment, corticosteroids reduce immunosuppressive signals, restore T‐cell function, and promote antitumor immune responses, resulting in enhanced tumor control.
John D. Martin, Koji Nagaoka, Myrofora Panagi, Akihiro Hosoi, Fotios Mpkeris, Pengwen Chen, Thahomina T. Khan, Margaret R. Martin, Changbo Sun, Chrysovalantis Voutouri, Maria Louca, Panagiotis Papageorgis, Akira Sumiyoshi, Nobuhiro Nitta, Kazuyoshi Takeda, Ichio Aoki, Kazunori Kataoka, Triantafyllos Stylianopoulos, Kazuhiro Kakimi, Horacio Cabral   +19 more
wiley   +1 more source

Utility of optimal proportion of tumor-infiltrating lymphocytes as a prognostic prediction of clinical outcome in intrahepatic cholangiocarcinoma: a single institution retrospective analysis. [PDF]

Diagn Pathol
Kunprom W, Poonsiri N, Intarawichian P, Sa-Ngiamwibool P, Sangkhamanon S, Thanee M, Loilome W, Titapun A, Jareanrat A, Thanasukarn V, Srisuk T, Luvira V, Eurboonyanun K, Promsorn J, Koonmee S, Prajumwongs P, Aphivatanasiri C.   +16 more
europepmc   +1 more source

Mutual Exclusion Analysis Shows that DUSP9 Negatively Regulates PD‐L1 Expression and Acts as a Target to Enhance Anti‐PD‐1 Efficacy

Advanced Science, EarlyView.
A mutually exclusive screening system is established to identify negative regulators of highly plastic genes. Dual specificity phosphatase (DUSP9) is a novel negative regulatory molecule of PD‐L1 by dephosphorylating STAT3, and acts as a target molecule in combination with PD‐1 antibody for tumor immunotherapy and a new clinical biomarker for ...
Yuzhe Hu, Ling Tang, Zheng Kuang, Danyi Huang, Ting Li, Gaofei Yin, Yingyu Chen, Wei Guo, Wenling Han, Pingzhang Wang   +9 more
wiley   +1 more source

Tumor-infiltrating lymphocytes-derived CD8⁺ clonotypes infiltrate the tumor tissue and mediate tumor regression in glioblastoma. [PDF]

Oncoimmunology
Arruda LCM, Karbach J, Kiselicki D, Altmannsberger HM, Sinelnikov E, Gustavus D, Hoffmeister H, Atmaca A, Jäger E.   +8 more
europepmc   +1 more source